vs
Apellis Pharmaceuticals, Inc.（APLS）与QUALYS, INC.（QLYS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是QUALYS, INC.的1.1倍（$199.9M vs $175.3M），QUALYS, INC.净利率更高（30.3% vs -29.5%，领先59.8%），QUALYS, INC.同比增速更快（10.1% vs -5.9%），QUALYS, INC.自由现金流更多（$74.9M vs $-14.3M），过去两年QUALYS, INC.的营收复合增速更高（9.6% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Qualys是总部位于美国加利福尼亚州福斯特城的科技企业，专注于云安全、合规管理及相关服务，为客户提供覆盖云环境的安全防护与合规解决方案，助力企业应对各类网络安全风险，满足不同行业的合规运营需求。
APLS vs QLYS — 直观对比
营收规模更大
APLS
是对方的1.1倍
$175.3M
营收增速更快
QLYS
高出16.0%
-5.9%
净利率更高
QLYS
高出59.8%
-29.5%
自由现金流更多
QLYS
多$89.2M
$-14.3M
两年增速更快
QLYS
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $175.3M |
| 净利润 | $-59.0M | $53.1M |
| 毛利率 | — | 83.4% |
| 营业利润率 | -25.6% | 33.6% |
| 净利率 | -29.5% | 30.3% |
| 营收同比 | -5.9% | 10.1% |
| 净利润同比 | -62.2% | 20.9% |
| 每股收益（稀释后） | $-0.40 | $1.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSQLYS
| Q4 25 | $199.9M | $175.3M | ||
| Q3 25 | $458.6M | $169.9M | ||
| Q2 25 | $178.5M | $164.1M | ||
| Q1 25 | $166.8M | $159.9M | ||
| Q4 24 | $212.5M | $159.2M | ||
| Q3 24 | $196.8M | $153.9M | ||
| Q2 24 | $199.7M | $148.7M | ||
| Q1 24 | $172.3M | $145.8M |
净利润APLSQLYS
| Q4 25 | $-59.0M | $53.1M | ||
| Q3 25 | $215.7M | $50.3M | ||
| Q2 25 | $-42.2M | $47.3M | ||
| Q1 25 | $-92.2M | $47.5M | ||
| Q4 24 | $-36.4M | $44.0M | ||
| Q3 24 | $-57.4M | $46.2M | ||
| Q2 24 | $-37.7M | $43.8M | ||
| Q1 24 | $-66.4M | $39.7M |
毛利率APLSQLYS
| Q4 25 | — | 83.4% | ||
| Q3 25 | — | 83.6% | ||
| Q2 25 | — | 82.4% | ||
| Q1 25 | — | 81.9% | ||
| Q4 24 | — | 81.8% | ||
| Q3 24 | — | 81.3% | ||
| Q2 24 | — | 82.2% | ||
| Q1 24 | — | 81.3% |
营业利润率APLSQLYS
| Q4 25 | -25.6% | 33.6% | ||
| Q3 25 | 48.7% | 35.3% | ||
| Q2 25 | -18.6% | 31.3% | ||
| Q1 25 | -50.0% | 32.4% | ||
| Q4 24 | -12.3% | 31.0% | ||
| Q3 24 | -24.0% | 29.2% | ||
| Q2 24 | -14.7% | 32.3% | ||
| Q1 24 | -36.0% | 30.7% |
净利率APLSQLYS
| Q4 25 | -29.5% | 30.3% | ||
| Q3 25 | 47.0% | 29.6% | ||
| Q2 25 | -23.6% | 28.8% | ||
| Q1 25 | -55.3% | 29.7% | ||
| Q4 24 | -17.1% | 27.6% | ||
| Q3 24 | -29.2% | 30.0% | ||
| Q2 24 | -18.9% | 29.4% | ||
| Q1 24 | -38.5% | 27.2% |
每股收益（稀释后）APLSQLYS
| Q4 25 | $-0.40 | $1.47 | ||
| Q3 25 | $1.67 | $1.39 | ||
| Q2 25 | $-0.33 | $1.29 | ||
| Q1 25 | $-0.74 | $1.29 | ||
| Q4 24 | $-0.30 | $1.19 | ||
| Q3 24 | $-0.46 | $1.24 | ||
| Q2 24 | $-0.30 | $1.17 | ||
| Q1 24 | $-0.54 | $1.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $250.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $561.2M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSQLYS
| Q4 25 | $466.2M | $250.3M | ||
| Q3 25 | $479.2M | $225.3M | ||
| Q2 25 | $370.0M | $194.0M | ||
| Q1 25 | $358.4M | $290.7M | ||
| Q4 24 | $411.3M | $232.2M | ||
| Q3 24 | $396.9M | $235.4M | ||
| Q2 24 | $360.1M | $281.2M | ||
| Q1 24 | $325.9M | $273.8M |
总债务APLSQLYS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSQLYS
| Q4 25 | $370.1M | $561.2M | ||
| Q3 25 | $401.2M | $529.4M | ||
| Q2 25 | $156.3M | $508.2M | ||
| Q1 25 | $164.2M | $498.0M | ||
| Q4 24 | $228.5M | $477.1M | ||
| Q3 24 | $237.1M | $449.6M | ||
| Q2 24 | $264.3M | $427.8M | ||
| Q1 24 | $266.7M | $404.2M |
总资产APLSQLYS
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $821.4M | $999.5M | ||
| Q1 25 | $807.3M | $996.5M | ||
| Q4 24 | $885.1M | $973.5M | ||
| Q3 24 | $901.9M | $908.3M | ||
| Q2 24 | $904.5M | $876.6M | ||
| Q1 24 | $831.9M | $861.8M |
负债/权益比APLSQLYS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $75.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $74.9M |
| 自由现金流率自由现金流/营收 | -7.1% | 42.8% |
| 资本支出强度资本支出/营收 | 0.1% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.42× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $304.4M |
8季度趋势，按日历期对齐
经营现金流APLSQLYS
| Q4 25 | $-14.2M | $75.7M | ||
| Q3 25 | $108.5M | $90.4M | ||
| Q2 25 | $4.4M | $33.8M | ||
| Q1 25 | $-53.4M | $109.6M | ||
| Q4 24 | $19.4M | $47.7M | ||
| Q3 24 | $34.1M | $61.0M | ||
| Q2 24 | $-8.3M | $49.8M | ||
| Q1 24 | $-133.0M | $85.5M |
自由现金流APLSQLYS
| Q4 25 | $-14.3M | $74.9M | ||
| Q3 25 | $108.3M | $89.5M | ||
| Q2 25 | $4.4M | $32.4M | ||
| Q1 25 | $-53.4M | $107.5M | ||
| Q4 24 | $19.3M | $41.9M | ||
| Q3 24 | — | $57.6M | ||
| Q2 24 | $-8.4M | $48.8M | ||
| Q1 24 | $-133.3M | $83.5M |
自由现金流率APLSQLYS
| Q4 25 | -7.1% | 42.8% | ||
| Q3 25 | 23.6% | 52.7% | ||
| Q2 25 | 2.5% | 19.8% | ||
| Q1 25 | -32.0% | 67.3% | ||
| Q4 24 | 9.1% | 26.3% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | -4.2% | 32.8% | ||
| Q1 24 | -77.3% | 57.2% |
资本支出强度APLSQLYS
| Q4 25 | 0.1% | 0.4% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.0% | 3.7% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.2% | 1.4% |
现金转化率APLSQLYS
| Q4 25 | — | 1.42× | ||
| Q3 25 | 0.50× | 1.80× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 2.31× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.14× | ||
| Q1 24 | — | 2.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
QLYS
| Sales Channel Through Intermediary | $88.6M | 51% |
| Sales Channel Directly To Consumer | $86.7M | 49% |
